Trial Profile
A Randomized, Controlled, Comparative Phase II Study Evaluating the Safety and Effectiveness of EVARREST Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Surgery.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fibrin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors Ethicon
- 27 Apr 2015 New trial record